Premium
Testicular vein thrombosis: Incidence of recurrent venous thromboembolism and survival
Author(s) -
Lenz Charles J,
McBane Robert D,
Cohoon Kevin P,
Janczak Dawid T,
Simmons Benjamin S,
Saadiq Rayya A,
Mimier Malgorzata,
Casanegra Ana I,
Daniels Paul R,
Wysokinski Waldemar E
Publication year - 2018
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/ejh.12985
Subject(s) - medicine , thrombosis , malignancy , incidence (geometry) , deep vein , surgery , etiology , cancer , cohort , vein , venous thrombosis , physics , optics
Purpose Testicular vein thrombosis (TVT) etiology, recurrence, and survival were compared with lower extremity deep vein thrombosis (DVT) in order to determine whether treatment guidelines for DVT could be applied to TVT. Patients and Methods An inception cohort of patients with confirmed TVT (January 1995‐October 2015) was compared to a control group of patients with lower extremity DVT matched by age, gender, and diagnosis date. Results Thirty‐nine men with TVT were identified; 15 (38%) with isolated TVT. Left testicular vein was affected in 77% patients; there were no cases of bilateral TVT. Cancer was over twofold more common in TVT patients (59% vs 28%, P = .01). Most cancers (78%) involved organs in proximity to the testicular vein. Although TVT patients were less frequently treated with anticoagulants (49% vs 97%, P = .0001), recurrence rates were similar to DVT group (TVT 4.2 vs DVT 1.1 per 100 patient‐years, P = .11). Despite higher cancer prevalence, survival rates were similar between groups (31% vs 28%; P = .34). Major bleeding events were rare (one patient per group). Conclusions Identifying TVT should prompt a search for a regional malignancy. Despite the high cancer prevalence and low utilization of anticoagulants, recurrent venous thrombosis and mortality rates are similar to DVT patients.